M. Dzabic, K. Bojakowski, E. Kurzejamska, G. Styczynski, P. Andziak, C

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cavallo Clinical Microbiology and Infection

Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real- time PCR findings in apparently immunocompetent patients: a case.

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

S. Sagedal, A. Hartmann, H. Rollag Clinical Microbiology and Infection

Vascular access in hemodialysis patients older than 80 years

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

How to discriminate contamination from bloodstream infection due to coagulase- negative staphylococci: a prospective study with 654 patients L. Elzi,

Vector control: a cornerstone in the malaria elimination campaign

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Retrospective study of CMV retinitis in patients with AIDS

T. Lazzarotto, B. Guerra, L. Gabrielli, M. Lanari, M.P. Landini

B. Gordts Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

Elements of design: the knowledge on which we build

Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product T.G. Bromage Clinical Microbiology.

S. Kurath, G. Halwachs-Baumann, W. Müller, B. Resch

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.

Laboratory diagnosis of Clostridium difficile disease

Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease Inge O. Baas, G. Johan A. Offerhaus, Ralph.

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Current experience in treating invasive zygomycosis with posaconazole

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Leptin, pre-existing vascular disease, and increased arteriovenous fistula maturation failure in dialysis patients Jwa-Kyung Kim, MD, Sun Ryoung Choi,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

D. Baud, C. Kebbi, J.-P. Külling, G. Greub

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Significance of cytomegalovirus infection in the failure of native arteriovenous fistula M. Dzabic, K. Bojakowski, E. Kurzejamska, G. Styczynski, P. Andziak, C. Söderberg-Nauclér, P. Religa Clinical Microbiology and Infection Volume 18, Issue 1, Pages E5-E7 (January 2012) DOI: 10.1111/j.1469-0691.2011.03691.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 No significant differences were observed in arteriovenous fistula (AVF) patency rates in patients with high cytomegalovirus (CMV) IgG levels. First tertile: <0.2 to 9.2 IU/mL, second tertile: >9.2 to 17.0 IU/mL and third tertile: >17 to >22 IU/mL. Clinical Microbiology and Infection 2012 18, E5-E7DOI: (10.1111/j.1469-0691.2011.03691.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Cytomegalovirus (CMV) protein-positive cells (brown) were found in the radial arteries of 38% of the patients evaluated while they were present in only 19% of the cephalic veins of the patients evaluated (IEA, immediate early antigen) (a). Alpha smooth muscle actin (α-SMA) was used as a positive control (b). Presence of CMV antigens in the vessels does not have prognostic value for arteriovenous fistula (AVF) patency (c). Clinical Microbiology and Infection 2012 18, E5-E7DOI: (10.1111/j.1469-0691.2011.03691.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions